Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

NCT: NCT04027777 · RECRUITING

NCT IDNCT04027777
StatusRECRUITING
Start Date2019-08-06
Completion2027-12-31

Brief Summary

Single-centre prospective observational study to validate the performance of the Aktiia SA optical blood pressure monitoring (OBPM) device at the wrist against blood pressure measurements obtained by double auscultation at the upper arm during four weeks

Frequently Asked Questions

What is Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation?

Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation is a clinical trial registered under NCT04027777. Current status: RECRUITING.

What is the status of NCT04027777?

The current status of NCT04027777 (Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation) is: RECRUITING.

When did Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation start?

Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation started on 2019-08-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑